o-chlorobenzylidenemalonitrile has been researched along with Nociceptive Pain in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annas, A; Berg, AL; Franzén, B; Lundgren, V; Meijer, T; Nyman, E; Ståhle, L | 1 |
1 other study(ies) available for o-chlorobenzylidenemalonitrile and Nociceptive Pain
| Article | Year |
|---|---|
Towards Development of a Dermal Pain Model: In Vitro Activation of Rat and Human Transient Receptor Potential Ankyrin Repeat 1 and Safe Dermal Injection of o-Chlorobenzylidene Malononitrile to Rat.
Topics: Animals; Calcitonin Gene-Related Peptide; Calcium Channels; Calcium Signaling; CHO Cells; Cricetulus; Disease Models, Animal; Dose-Response Relationship, Drug; Ganglia, Spinal; HEK293 Cells; Humans; Injections, Intradermal; Male; Nerve Tissue Proteins; Nociception; Nociceptive Pain; o-Chlorobenzylidenemalonitrile; Pain Threshold; Rats, Wistar; Skin; Time Factors; Transfection; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPC Cation Channels | 2015 |